REQUEST A DEMO
Total
USD $0.00
Search more companies

Soluciones en Innovacion Farmaceutica S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Soluciones en Innovacion Farmaceutica S.A.S. Profile Updated: July 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Soluciones en Innovacion Farmaceutica S.A.S. is a company in Colombia, with a head office in Medellin. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on January 31, 2014. There are currently 4 (2024) people employed by Soluciones en Innovacion Farmaceutica S.A.S.. From the latest financial highlights, Soluciones en Innovacion Farmaceutica S.A.S. reported a net sales revenue drop of 4.54% in 2023. Over the same period, its total assets grew by 10.5%. In 2023, Soluciones en Innovacion Farmaceutica S.A.S.’s net profit margin increased by 14.39%.

Headquarters
Calle 6 43 C 08 Of 306 Ed Oficentro Astorga
Medellin; Antioquia;

Contact Details: Purchase the Soluciones en Innovacion Farmaceutica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Soluciones en Innovacion Farmaceutica S.A.S. report to view the information.
Outstanding Shares:
Purchase the Soluciones en Innovacion Farmaceutica S.A.S. report to view the information.
Incorporation Date:
January 31, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Soluciones en Innovacion Farmaceutica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-4.54%
Total operating revenue
-3.92%
Operating profit (EBIT)
108.22%
EBITDA
103.31%
Net Profit (Loss) for the Period
552.9%
Total assets
10.5%
Total equity
104.99%
Operating Profit Margin (ROS)
11.69%
Net Profit Margin
14.39%
Return on Equity (ROE)
35.14%
Debt to Equity Ratio
-0.06%
Quick Ratio
1.79%
Cash Ratio
0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?